Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
N-Power Medicine has built one of the largest community-based prospective clinical research networks in the U.S., integrating clinical trial participation into routine care for cancer patients. Its Kaleido Registry has enrolled over 12,000 patients with a 95% consent rate. The company’s technology and human support model have enabled more efficient trial enrollment and data collection for pharmaceutical partners. Strategic partnerships include Merck & Co., with $85M+ raised to date. In January 2025, N-Power acquired Syapse to further expand its network and capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on N-Power Medicine.